Literature DB >> 20122900

Structural characterization of BRCT-tetrapeptide binding interactions.

Prem Raj B Joseph1, Ziyan Yuan, Eric A Kumar, G L Lokesh, Smitha Kizhake, Krishna Rajarathnam, Amarnath Natarajan.   

Abstract

BRCT(BRCA1) plays a major role in DNA repair pathway, and does so by recognizing the conserved sequence pSXXF in its target proteins. Remarkably, tetrapeptides containing pSXXF motif bind with high specificity and micromolar affinity. Here, we have characterized the binding interactions of pSXXF tetrapeptides using NMR spectroscopy and calorimetry. We show that BRCT is dynamic and becomes structured on binding, that pSer and Phe residues dictate overall binding, and that the binding affinities of the tetrapeptides are intimately linked to structural and dynamic changes both in the BRCT(BRCA1) and tetrapeptides. These results provide critical insights for designing high-affinity BRCT(BRCA1) inhibitors. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122900      PMCID: PMC2834807          DOI: 10.1016/j.bbrc.2010.01.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

Authors:  S B Cantor; D W Bell; S Ganesan; E M Kass; R Drapkin; S Grossman; D C Wahrer; D C Sgroi; W S Lane; D A Haber; D M Livingston
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

2.  Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.

Authors:  Eric N Shiozaki; Lichuan Gu; Nieng Yan; Yigong Shi
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

3.  Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

Authors:  Maria Victoria E Botuyan; Yves Nominé; Xiaochun Yu; Nenad Juranic; Slobodan Macura; Junjie Chen; Georges Mer
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

4.  DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains.

Authors:  Xiaochun Yu; Junjie Chen
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

5.  Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.

Authors:  R Scott Williams; Megan S Lee; D Duong Hau; J N Mark Glover
Journal:  Nat Struct Mol Biol       Date:  2004-05-09       Impact factor: 15.369

6.  Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.

Authors:  Julie A Clapperton; Isaac A Manke; Drew M Lowery; Timmy Ho; Lesley F Haire; Michael B Yaffe; Stephen J Smerdon
Journal:  Nat Struct Mol Biol       Date:  2004-05-09       Impact factor: 15.369

7.  BRCT repeats as phosphopeptide-binding modules involved in protein targeting.

Authors:  Isaac A Manke; Drew M Lowery; Anhco Nguyen; Michael B Yaffe
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

8.  The BRCT domain is a phospho-protein binding domain.

Authors:  Xiaochun Yu; Claudia Christiano Silva Chini; Miao He; Georges Mer; Junjie Chen
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  Structural basis for differential binding of the interleukin-8 monomer and dimer to the CXCR1 N-domain: role of coupled interactions and dynamics.

Authors:  Aishwarya Ravindran; Prem Raj B Joseph; Krishna Rajarathnam
Journal:  Biochemistry       Date:  2009-09-22       Impact factor: 3.162

View more
  11 in total

Review 1.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

2.  Structure-activity relationship studies to probe the phosphoprotein binding site on the carboxy terminal domains of the breast cancer susceptibility gene 1.

Authors:  Ziyan Yuan; Eric A Kumar; Smitha Kizhake; Amarnath Natarajan
Journal:  J Med Chem       Date:  2011-05-26       Impact factor: 7.446

3.  Exploiting the P-1 pocket of BRCT domains toward a structure guided inhibitor design.

Authors:  Ziyan Yuan; Eric A Kumar; Stephen J Campbell; Nicholas Y Palermo; Smitha Kizhake; J N Mark Glover; Amarnath Natarajan
Journal:  ACS Med Chem Lett       Date:  2011-10-13       Impact factor: 4.345

4.  2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study.

Authors:  Qianyi Chen; Vashti C Bryant; Hernando Lopez; David L Kelly; Xu Luo; Amarnath Natarajan
Journal:  Bioorg Med Chem Lett       Date:  2011-02-17       Impact factor: 2.823

5.  Irreversible binding of an anticancer compound (BI-94) to plasma proteins.

Authors:  Nagsen Gautam; Rhishikesh Thakare; Sandeep Rana; Amarnath Natarajan; Yazen Alnouti
Journal:  Xenobiotica       Date:  2015-04-14       Impact factor: 1.908

6.  Computational and experimental studies of the interaction between phospho-peptides and the C-terminal domain of BRCA1.

Authors:  Victor M Anisimov; Arturas Ziemys; Smitha Kizhake; Ziyan Yuan; Amarnath Natarajan; Claudio N Cavasotto
Journal:  J Comput Aided Mol Des       Date:  2011-11-16       Impact factor: 3.686

7.  Synthesis of unnatural amino acid derivatives via palladium catalyzed 1,4 addition of boronic acids.

Authors:  Devalina Ray; Abijah M Nyong; Amarnath Natarajan
Journal:  Tetrahedron Lett       Date:  2010-05-12       Impact factor: 2.415

8.  Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option.

Authors:  Ziyan Yuan Pessetto; Ying Yan; Tadayoshi Bessho; Amarnath Natarajan
Journal:  Breast Cancer Res Treat       Date:  2012-05-06       Impact factor: 4.872

9.  Casitas B-Lineage Lymphoma RING Domain Inhibitors Protect Mice against High-Fat Diet-Induced Obesity and Insulin Resistance.

Authors:  Min Wu; Lin Sun; Ziyan Yuan Pessetto; Zhihe Zang; Xingliang Xie; Ling Zhong; Qing Su; Wang Zan; Xiurong Gao; Yan Zhao; Yiyi Sun
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

10.  The paradox of conformational constraint in the design of Cbl(TKB)-binding peptides.

Authors:  Eric A Kumar; Qianyi Chen; Smitha Kizhake; Carol Kolar; Myungshim Kang; Chia-En A Chang; Gloria E O Borgstahl; Amarnath Natarajan
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.